Invention Grant
- Patent Title: HCV NS3 protease inhibitors
-
Application No.: US14358050Application Date: 2012-11-09
-
Publication No.: US09328138B2Publication Date: 2016-05-03
- Inventor: Michael T. Rudd , John McCauley , Nigel Liverton , Christiane Grisé-Bard , Marie-Christine Brochu , Sylvie Charron , Virender Aulakh , Benoit Bachand , Patrick Beaulieu , Helmi Zaghdane , Yongxin Han , Marco Ferrara , Steven Harper , Vincenzo Summa , Samuel Chackalamannil , Srikanth Venkatraman , Unmesh Shah , Francisco Velazquez
- Applicant: Merck Sharp & Dohme Corp. , MSD Italia S.R.L. , Merck Canada Inc.
- Applicant Address: IT Rome US NJ Rahway
- Assignee: MSD Italia S.R.L.,Merck Sharp & Dohme Corp.
- Current Assignee: MSD Italia S.R.L.,Merck Sharp & Dohme Corp.
- Current Assignee Address: IT Rome US NJ Rahway
- Agent Alysia A. Finnegan; Anna L. Cocuzzo
- International Application: PCT/US2012/064270 WO 20121109
- International Announcement: WO2013/074386 WO 20130523
- Main IPC: A61K38/06
- IPC: A61K38/06 ; C07K5/08 ; C07K5/078 ; C07K5/083 ; C07K5/087 ; A61K38/21 ; C07K5/097 ; A61K31/4745 ; A61K31/5377 ; A61K31/675 ; A61K31/7056 ; A61K38/00 ; A61K38/12
Abstract:
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
Public/Granted literature
- US20140296136A1 HCV NS3 PROTEASE INHIBITORS Public/Granted day:2014-10-02
Information query
IPC分类:
